The One Big Beautiful Bill Act (OBBBA) is prompting strategic discussions and action across the healthcare industry, according to a new Q-Centrix survey. Findings reveal that while leaders anticipate wide-ranging operational and financial impacts, most see clinical data as a critical tool for navigating the changes ahead.
Respondents comprised those from non-rural hospitals and health systems (63%), rural hospitals (15%), life sciences organizations (11%), and payer organizations (13%). Total complete responses: 103.
